Zein Nanoparticles with Flavonoids for Treating Leishmaniasis
Author Information
Author(s): Neves Monica Araujo das, de Jesus Caroline Martins, de Oliveira Jhones Luiz, Buna Samuel dos Santos Soares, Silva Lucilene Amorim, Fraceto Leonardo Fernandes, da Rocha Cláudia Quintino
Primary Institution: Federal University of Maranhão
Hypothesis
Can zein nanoparticles encapsulate flavonoids from Fridericia platyphylla to improve treatment for leishmaniasis?
Conclusion
The combination of DCMF from Fridericia platyphylla with zein nanoparticles shows promise for treating leishmaniasis by enhancing efficacy and reducing toxicity.
Supporting Evidence
- ZNP-DCMF showed an IC50 of 36.33 μg/mL against promastigotes.
- ZNP-DCMF was non-cytotoxic to RAW264.7 macrophages with a CC50 > 500 μg/mL.
- The selectivity index for ZNP-DCMF increased significantly compared to DCMF alone.
- Encapsulation efficiency of DCMF in zein nanoparticles was 94.6%.
- ZNP-DCMF remained stable for 49 days without significant changes.
- Zein nanoparticles are biocompatible and biodegradable.
Takeaway
Researchers created tiny particles from corn protein to carry plant compounds that can help fight a disease called leishmaniasis, making the treatment safer and more effective.
Methodology
Zein nanoparticles were synthesized and characterized for their ability to encapsulate a nonpolar fraction from Fridericia platyphylla, followed by testing for antileishmanial activity against Leishmania amazonensis.
Potential Biases
Potential bias in the selection of plant extracts and methods used for testing.
Limitations
The study does not address long-term effects or clinical trials in humans.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website